Bml Capital Management, LLC / CARM
Bml Capital Management, LLC’s Carisma Therapeutics Inc Position
Does Bml Capital Management, LLC own Carisma Therapeutics Inc (CARM)? Not currently — the last reported position was 411.4K shares worth $1M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$1M
Q1 2023
Shares
411.4K
% of Portfolio
+1.10%
Quarters Held
1
position exited
Position History CARM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2023 | 411.4K | $1M | +1.10% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bml Capital Management, LLC’s full portfolio or all institutional holders of CARM.